Fibrosis and hypertensive heart disease

Area of Science:

• Cardiovascular Biology
• Cardiac Pathology
• Vascular Remodeling

Background:

• The normal myocardium comprises cardiac myocytes and non-cardiomyocytes like endothelial cells, smooth muscle cells, and fibroblasts.
• Hypertensive heart disease is characterized by structural remodeling affecting both muscular and non-muscular myocardial compartments.
• Pathologic hypertrophy and subsequent ventricular dysfunction are linked to myocardial quality, not solely quantity, increasing adverse cardiovascular event risk.

Purpose of the Study:

• To review factors regulating myocardial compartment growth.
• To examine signals promoting adverse remodeling of intramyocardial coronary arteries and arterioles via fibrous tissue deposition.

Main Methods:

• Literature review of factors regulating myocardial growth.
• Analysis of signaling pathways involved in hypertensive heart disease remodeling.

Main Results:

• Myocardial quality, rather than quantity, is critical in pathologic hypertrophy and ventricular dysfunction.
• Adverse remodeling of intramyocardial vessels by fibrous tissue is a key feature.

Conclusions:

• Understanding the quality of myocardial tissue is crucial for addressing hypertensive heart disease.
• Targeting signals that promote fibrous tissue deposition in coronary arteries may mitigate adverse cardiovascular events.